Logo image
Back
Endoluminal treatment of type IA endoleak with Onyx
Journal article   Peer reviewed

Endoluminal treatment of type IA endoleak with Onyx

Joseph L Grisafi, Guillaume Boiteau, Elizabeth Detschelt, Jonathan Potts, Paul Kiproff and Satish C Muluk
Journal of vascular surgery, v 52(5), pp 1346-1349
01 Nov 2010
DOI: https://doi.org/10.1016/j.jvs.2010.06.021
PMID: 20655689
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://doi.org/10.1016/j.jvs.2010.06.021View
Published, Version of Record (VoR) Restricted

Abstract

Aged, 80 and over Aortic Aneurysm, Abdominal - diagnostic imaging Aortic Aneurysm, Abdominal - surgery Blood Vessel Prosthesis Blood Vessel Prosthesis Implantation - adverse effects Blood Vessel Prosthesis Implantation - instrumentation Embolization, Therapeutic - instrumentation Endoleak - diagnostic imaging Endoleak - etiology Endoleak - therapy Equipment Design Female Humans Prosthesis Design Tomography, X-Ray Computed Treatment Outcome
Type IA endoleaks associated with endovascular aortic aneurysm repair are typically treated with endovascular adjuncts. Technical failure results when such maneuvers are unsuccessful, and endograft removal may, unfortunately, become necessary. The novel management of a recalcitrant type IA endoleak using the artificial embolization device, Onyx (Micro Therapeutics Inc, Irvine, Calif) is presented for the case of a nonagenarian with prohibitive surgical risk after conventional techniques had failed.

Metrics

5 Record Views
30 citations in Web of Science
35 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Peripheral Vascular Disease
Surgery
Logo image